Life after GLP-1s: How to sustain weight loss
It should come as no surprise that GLP-1 receptor agonists have revolutionized the management of obesity and metabolic syndrome. These drugs have shown extraordinary promise in regulating appetite, promoting weight loss, and improving blood sugar control. Nearly one in eight adults (twelve percent) have taken a GLP-1 agonist, and forty-three percent of adults diagnosed with […]
Weight loss drug stigma shows society still holds negative attitudes towards body weight and obesity
Since Wegovy received approval as a weight loss treatment in 2021, there has been huge demand for GLP-1 drugs. These drugs reduce hunger and suppress the “food noise” that can make it difficult to lose weight.
Food formulation and precision nutrition in the Ozempic era: ‘There’s an entire secondary market that can come from any breakthrough technology’
“No one knows exactly what is the impact of these new [GLP-1 receptor agonist] drugs Ozempic or Mounjaro… but something is happening because protein overall became [a trend],” JBS meat magnate Wesley Batista observed at Rothschild’s consumer conference in London last month. The data suggest a slightly more nuanced picture, as protein was hot long […]
This Popular Diabetes Drug Could Reduce Cravings for Alcohol and Drugs
New research suggests that diabetes and weight-loss drugs known as GLP-1 receptor agonists may also help treat alcohol and drug addiction. A widely used group of medications originally developed to manage diabetes and obesity may also hold promise for treating alcohol and drug addiction, according to new research published in the Journal of the Endocrine […]
New obesity drug boosts GLP-1 weight loss without added side effects
A new class of weight-loss drug has shown it can significantly boost weight loss when paired with GLP-1 therapy – without adding side effects – in a mid-stage clinical trial, pointing to a powerful new combination approach to tackling obesity. Continue Reading Category: Obesity, Illnesses and conditions, Body and Mind Tags: Obesity, Weight Loss, GLP-1 […]
A Long-Awaited Longevity Mystery Solved
If you’re interested in the science of healthspan and longevity, you’ve likely heard of the naked mole rat, a remarkable outlier among mammals that defies the laws of biologic aging. For nearly 30 years, we didn’t know what accounted for this phenomenon, but a compelling new report sheds light on a pathway that was only […]
Weight-loss scams surge as demand for GLP-1 drugs grows
Over the last couple of years, popular weight loss drugs including Ozempic, Wegovy, Mounjaro, and Zepbound have revolutionized weight loss in the U.S. In a country where the Centers for Disease Control estimates around 40% of adults are overweight or obese, the drugs are proving to be life-changing and even lifesaving for many people. About […]
We Asked Mars Wrigley’s ‘Chief Halloween Officer’ About This Year’s Top Candy Trends—Here’s What He Had To Say
Getty Images A range of tastes and trends are expected to land in candy baskets this year. Key Takeaways Candy is expected to account for about one-third of the $13 billion Americans are set to spend on Halloween this year. While chocolate remains the bedrock of Halloween, experts say tastes are shifting toward fruit flavors, […]
Are you a taperer, microdoser or maintainer? The do’s and DON’TS of coming off fat jabs whatever gang you’re in
EVERYONE talks about starting weight loss jabs – but what about stopping them? If you’re worried about the food noise roaring back with a vengeance, you’re not alone. Here, we reveal the secrets to maintaining your goal weight – on and off drugs like Mounjaro and Wegovy. GettyYou’ve hit your goal weight – well done! […]
Acute effects of GIP and GLP‐1 receptor antagonism in totally pancreatectomized individuals: A randomized double‐blind, placebo‐controlled crossover study
Abstract Aims The incretin hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) influence metabolism through strong effects on pancreatic hormone secretion but also in a pancreas-independent manner. Here, we investigated the isolated extrapancreatic effects of endogenous GIP and GLP-1 by applying hormone receptor antagonists in totally pancreatectomized individuals. Methods Twelve totally pancreatectomized individuals […]